Pro Total Stockholder Equity vs Common Stock Total Equity Analysis

PME Stock

283.31 2.50 0.87%

Pro Medicus financial indicator trend analysis is much more than just breaking down Pro Medicus prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pro Medicus is a good investment. Please check the relationship between Pro Medicus Total Stockholder Equity and its Common Stock Total Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Medicus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Stockholder Equity vs Common Stock Total Equity

Total Stockholder Equity vs Common Stock Total Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pro Medicus Total Stockholder Equity account and Common Stock Total Equity. At this time, the significance of the direction appears to have strong relationship.

The correlation between Pro Medicus' Total Stockholder Equity and Common Stock Total Equity is 0.69. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Pro Medicus, assuming nothing else is changed. The correlation between historical values of Pro Medicus' Total Stockholder Equity and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Pro Medicus are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Total Stockholder Equity i.e., Pro Medicus' Total Stockholder Equity and Common Stock Total Equity go up and down completely randomly.

Correlation Coefficient

0.69

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Most indicators from Pro Medicus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pro Medicus current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pro Medicus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 36.7 M in 2025. Tax Provision is likely to gain to about 40.7 M in 2025

	2022	2023	2024	2025 (projected)
Total Operating Expenses	8.5M	10.1M	11.6M	9.6M
EBITDA	94.1M	120.7M	138.8M	145.7M

Total Operating Expenses Ebitda

Pro Medicus fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Liab	Other Assets
Total Assets		-0.64	0.83	0.99	1.0	0.0	0.99	-0.8	0.99	0.96	0.9	0.97	1.0	1.0	0.73	0.8	0.95	-0.48	-0.92	0.98	-0.26	1.0	-0.26	0.88	0.93	-0.06
Short Long Term Debt Total	-0.64		-0.21	-0.63	-0.62	0.05	-0.65	0.59	-0.62	-0.6	-0.64	-0.63	-0.64	-0.65	-0.37	-0.39	-0.66	0.35	0.77	-0.65	0.35	-0.64	0.55	-0.46	-0.65	-0.13
Other Current Liab	0.83	-0.21		0.84	0.82	-0.17	0.84	-0.64	0.81	0.78	0.72	0.75	0.81	0.83	0.72	0.73	0.8	-0.49	-0.6	0.83	-0.33	0.82	0.24	0.77	0.8	-0.08
Total Current Liabilities	0.99	-0.63	0.84		0.99	-0.01	0.98	-0.84	0.98	0.96	0.93	0.96	0.99	0.99	0.73	0.78	0.96	-0.47	-0.93	0.99	-0.24	0.99	-0.23	0.84	0.94	-0.07
Total Stockholder Equity	1.0	-0.62	0.82	0.99		0.01	0.98	-0.77	1.0	0.95	0.88	0.96	1.0	0.99	0.69	0.81	0.93	-0.44	-0.91	0.97	-0.24	1.0	-0.29	0.91	0.91	-0.09
Property Plant And Equipment Net	0.0	0.05	-0.17	-0.01	0.01		-0.03	0.09	0.02	0.01	-0.06	0.04	0.0	-0.03	-0.25	-0.1	-0.04	0.23	-0.05	-0.03	0.29	0.0	0.06	0.02	-0.1	-0.05
Current Deferred Revenue	0.99	-0.65	0.84	0.98	0.98	-0.03		-0.79	0.97	0.95	0.89	0.97	0.97	0.99	0.75	0.8	0.98	-0.55	-0.9	0.99	-0.32	0.98	-0.19	0.86	0.96	0.02
Net Debt	-0.8	0.59	-0.64	-0.84	-0.77	0.09	-0.79		-0.76	-0.74	-0.97	-0.79	-0.79	-0.81	-0.74	-0.5	-0.86	0.56	0.89	-0.86	0.22	-0.79	0.15	-0.44	-0.87	-0.2
Retained Earnings	0.99	-0.62	0.81	0.98	1.0	0.02	0.97	-0.76		0.95	0.87	0.95	1.0	0.99	0.67	0.8	0.92	-0.4	-0.91	0.96	-0.22	1.0	-0.3	0.91	0.89	-0.12
Accounts Payable	0.96	-0.6	0.78	0.96	0.95	0.01	0.95	-0.74	0.95		0.84	0.95	0.95	0.94	0.74	0.8	0.92	-0.44	-0.87	0.95	-0.19	0.95	-0.29	0.85	0.91	-0.08
Cash	0.9	-0.64	0.72	0.93	0.88	-0.06	0.89	-0.97	0.87	0.84		0.89	0.89	0.9	0.77	0.64	0.93	-0.54	-0.93	0.94	-0.23	0.89	-0.2	0.6	0.93	0.14
Non Current Assets Total	0.97	-0.63	0.75	0.96	0.96	0.04	0.97	-0.79	0.95	0.95	0.89		0.96	0.96	0.78	0.79	0.96	-0.55	-0.92	0.97	-0.22	0.96	-0.31	0.83	0.94	0.05
Cash And Short Term Investments	1.0	-0.64	0.81	0.99	1.0	0.0	0.97	-0.79	1.0	0.95	0.89	0.96		0.99	0.68	0.79	0.93	-0.42	-0.93	0.97	-0.24	1.0	-0.29	0.89	0.9	-0.1
Net Receivables	1.0	-0.65	0.83	0.99	0.99	-0.03	0.99	-0.81	0.99	0.94	0.9	0.96	0.99		0.72	0.79	0.96	-0.5	-0.92	0.98	-0.28	0.99	-0.24	0.87	0.94	-0.04
Common Stock Total Equity	0.73	-0.37	0.72	0.73	0.69	-0.25	0.75	-0.74	0.67	0.74	0.77	0.78	0.68	0.72		0.66	0.83	-0.84	-0.63	0.79	-0.46	0.69	0.02	0.52	0.86	0.27
Common Stock Shares Outstanding	0.8	-0.39	0.73	0.78	0.81	-0.1	0.8	-0.5	0.8	0.8	0.64	0.79	0.79	0.79	0.66		0.76	-0.46	-0.61	0.78	-0.27	0.79	-0.17	0.8	0.74	-0.04
Non Current Liabilities Total	0.95	-0.66	0.8	0.96	0.93	-0.04	0.98	-0.86	0.92	0.92	0.93	0.96	0.93	0.96	0.83	0.76		-0.65	-0.9	0.99	-0.34	0.94	-0.14	0.75	1.0	0.13
Inventory	-0.48	0.35	-0.49	-0.47	-0.44	0.23	-0.55	0.56	-0.4	-0.44	-0.54	-0.55	-0.42	-0.5	-0.84	-0.46	-0.65		0.43	-0.57	0.63	-0.44	-0.14	-0.29	-0.68	-0.45
Other Stockholder Equity	-0.92	0.77	-0.6	-0.93	-0.91	-0.05	-0.9	0.89	-0.91	-0.87	-0.93	-0.92	-0.93	-0.92	-0.63	-0.61	-0.9	0.43		-0.92	0.15	-0.93	0.44	-0.69	-0.88	0.0
Total Liab	0.98	-0.65	0.83	0.99	0.97	-0.03	0.99	-0.86	0.96	0.95	0.94	0.97	0.97	0.98	0.79	0.78	0.99	-0.57	-0.92		-0.3	0.97	-0.19	0.8	0.98	0.04
Property Plant And Equipment Gross	-0.26	0.35	-0.33	-0.24	-0.24	0.29	-0.32	0.22	-0.22	-0.19	-0.23	-0.22	-0.24	-0.28	-0.46	-0.27	-0.34	0.63	0.15	-0.3		-0.24	-0.24	-0.26	-0.37	-0.28
Total Current Assets	1.0	-0.64	0.82	0.99	1.0	0.0	0.98	-0.79	1.0	0.95	0.89	0.96	1.0	0.99	0.69	0.79	0.94	-0.44	-0.93	0.97	-0.24		-0.28	0.89	0.91	-0.09
Short Term Debt	-0.26	0.55	0.24	-0.23	-0.29	0.06	-0.19	0.15	-0.3	-0.29	-0.2	-0.31	-0.29	-0.24	0.02	-0.17	-0.14	-0.14	0.44	-0.19	-0.24	-0.28		-0.26	-0.12	0.16
Common Stock	0.88	-0.46	0.77	0.84	0.91	0.02	0.86	-0.44	0.91	0.85	0.6	0.83	0.89	0.87	0.52	0.8	0.75	-0.29	-0.69	0.8	-0.26	0.89	-0.26		0.71	-0.21
Other Liab	0.93	-0.65	0.8	0.94	0.91	-0.1	0.96	-0.87	0.89	0.91	0.93	0.94	0.9	0.94	0.86	0.74	1.0	-0.68	-0.88	0.98	-0.37	0.91	-0.12	0.71		0.16
Other Assets	-0.06	-0.13	-0.08	-0.07	-0.09	-0.05	0.02	-0.2	-0.12	-0.08	0.14	0.05	-0.1	-0.04	0.27	-0.04	0.13	-0.45	0.0	0.04	-0.28	-0.09	0.16	-0.21	0.16

Click cells to compare fundamentals

Pro Medicus Account Relationship Matchups

Pro Medicus fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	125.6M	157.1M	202.1M	257.4M	296.0M	310.8M
Short Long Term Debt Total	2.6M	2.3M	1.9M	2.1M	2.4M	1.8M
Other Current Liab	5.6M	8.2M	10.0M	12.8M	14.7M	15.5M
Total Current Liabilities	17.6M	26.9M	30.9M	34.6M	39.7M	41.7M
Total Stockholder Equity	81.7M	101.7M	138.8M	187.7M	215.9M	226.7M
Property Plant And Equipment Net	3.0M	2.6M	2.2M	2.4M	2.7M	3.0M
Current Deferred Revenue	8.9M	10.1M	12.6M	17.1M	19.6M	20.6M
Net Debt	(39.4M)	(61.4M)	(89.4M)	(58.0M)	(52.2M)	(49.6M)
Retained Earnings	66.9M	92.6M	127.1M	173.4M	199.4M	209.3M
Accounts Payable	872K	1.6M	1.0M	1.7M	2.0M	2.1M
Cash	42.0M	63.7M	91.2M	60.1M	69.1M	72.5M
Non Current Assets Total	38.0M	37.2M	38.3M	50.9M	58.5M	61.4M
Cash And Short Term Investments	61.8M	90.6M	121.5M	155.4M	178.7M	187.7M
Net Receivables	24.4M	27.4M	40.7M	49.2M	56.6M	59.4M
Common Stock Shares Outstanding	104.6M	104.6M	104.6M	104.7M	120.4M	111.9M
Liabilities And Stockholders Equity	125.6M	157.1M	202.1M	257.4M	296.0M	310.8M
Non Current Liabilities Total	26.3M	28.5M	32.5M	35.1M	40.4M	42.4M
Inventory	34K	77K	55K	49K	44.1K	75.3K
Other Stockholder Equity	(51.6M)	(68.9M)	(94.5M)	(129.1M)	(116.2M)	(110.4M)
Total Liab	43.9M	55.3M	63.4M	69.7M	80.2M	84.2M
Property Plant And Equipment Gross	6.9M	6.3M	6.3M	2.4M	2.7M	4.9M
Total Current Assets	87.6M	119.8M	163.8M	206.6M	237.5M	249.4M
Accumulated Other Comprehensive Income	12.8M	7.2M	9.7M	(9.3M)	(10.7M)	(10.1M)
Short Term Debt	574K	604K	1.4M	553K	636.0K	604.2K
Other Liab	21.0M	24.2M	26.8M	31.3M	36.0M	37.8M
Other Assets	13.2M	40.5M	1.0	12.4M	1.15	1.09
Other Current Assets	1.3M	1.8M	1.6M	1.9M	1.7M	950.4K
Property Plant Equipment	2.8M	3.0M	2.6M	2.2M	2.5M	2.6M
Non Currrent Assets Other	30.0K	(1.0)	242K	40K	46K	48.3K
Intangible Assets	20.0M	22.3M	21.3M	20.1M	23.1M	24.2M
Net Tangible Assets	41.3M	61.7M	79.4M	117.4M	135.0M	141.8M
Long Term Debt Total	1.8M	2.0M	1.7M	1.2M	1.4M	1.0M
Net Invested Capital	81.7M	101.7M	138.8M	187.7M	215.9M	226.7M
Net Working Capital	69.9M	93.0M	132.9M	172.0M	197.8M	207.7M
Capital Lease Obligations	2.6M	2.3M	1.9M	2.1M	1.9M	1.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Pro Stock Analysis

When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC